We are proud to announce that Seerlinq HeartCore is now a certified Class II(b) medical device under the EU MDR 2017/745 regulation.

More than 200 patients have already joined our program, and we’re working with over 50 psychicians across Slovakia!

Seerlinq is proud to have been recognized in the Deloitte Technology Fast 50 CE 2024, celebrating our innovation in healthcare!

We are continuously working on our research to improve the quality of our technologies.

Seerlinq Has an International Reach!

Our Patients’ First Year Without Hospitalization!

Our network of patients and specialists is continually growing!

Seerlinq is now covered by all health insurance companies in Slovakia.

We Are Now Available to All Heart Failure Patients in Slovakia.

We’ve launched our first product for heart failure patients in Slovakia, a significant step forward in our mission!

Seerlinq presented at the largest heart failure conference in the world, held in Lisbon.

Two cases were accepted for oral presentation at ESC congresses!